Preclinical murine tumor models: a structural and functional perspective

Preclinical murine tumor models: a structural and functional perspective

The goal of this review is to pinpoint the specific features, including the weaknesses, of various tumor models, and to discuss the reasons why treatments that are efficient in murine tumor models often do not work in clinics. In a detailed comparison of transplanted and spontaneous tumor models, we...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Guerin, MV, Finisguerra, V, Van den Eynde, BJ, Bercovici, N, Trautmann, T
Natura:	Journal article
Lingua:	English
Pubblicazione:	eLife Sciences Publications, Ltd 2020

Documenti analoghi

Preclinical murine tumor models: A structural and functional perspective
di: Marion V Guerin, et al.
Pubblicazione: (2020-01-01)

Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells
di: Dvorakova, T, et al.
Pubblicazione: (2024)

Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression
di: Finisguerra, V, et al.
Pubblicazione: (2023)

The Remarkable Plasticity of Macrophages: A Chance to Fight Cancer
di: Nadège Bercovici, et al.
Pubblicazione: (2019-07-01)

Arid5a: A missing link between EMT and tumoral immune resistance
di: Van den Eynde, BJ
Pubblicazione: (2021)

TGFβ blocks IFNα/β release and tumor rejection in spontaneous mammary tumors
di: Marion V. Guerin, et al.
Pubblicazione: (2019-09-01)

Tryptophan 2,3-dioxygenase expression identified in murine decidual stromal cells is not essential for feto-maternal tolerance
di: Hoffmann, D, et al.
Pubblicazione: (2020)

Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells
di: Tereza Dvorakova, et al.
Pubblicazione: (2024-09-01)

Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression
di: Benoit J Van den Eynde, et al.
Pubblicazione: (2023-05-01)

Local IFNα enhances the anti-tumoral efficacy of systemic anti-PD1 to prevent tumor relapse
di: Maxime Thoreau, et al.
Pubblicazione: (2020-10-01)

Functional differences between proteasome subtypes
di: Abi Habib, J, et al.
Pubblicazione: (2022)

Novel preclinical murine model of trauma-induced elbow stiffness
di: Stephanie N. Moore-Lotridge, et al.
Pubblicazione: (2018-09-01)

Combining personalized neoantigen vaccination with chemotherapy and anti-PD-1 to treat NSCLC
di: Leung, CSK, et al.
Pubblicazione: (2022)

Tryptophan-degrading enzymes in tumoral immune resistance
di: Nicolas van Baren, et al.
Pubblicazione: (2016-11-01)

Tryptophan 2,3-Dioxygenase Expression Identified in Murine Decidual Stromal Cells Is Not Essential for Feto-Maternal Tolerance
di: Delia Hoffmann, et al.
Pubblicazione: (2020-12-01)

TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism
di: Canè, S, et al.
Pubblicazione: (2021)

Combining Photodynamic Therapy with Immunostimulatory Nanoparticles Elicits Effective Anti-Tumor Immune Responses in Preclinical Murine Models
di: Ruben Victor Huis in ‘t Veld, et al.
Pubblicazione: (2021-09-01)

Circulating tumor cell-derived preclinical models: current status and future perspectives
di: Zuzana Kahounová, et al.
Pubblicazione: (2023-08-01)

The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression
di: Julia M. Weiss, et al.
Pubblicazione: (2017-10-01)

Constitutive IDO1 expression in human tumors is driven by cyclooxygenase-2 and mediates intrinsic immune resistance
di: Hennequart, M, et al.
Pubblicazione: (2017)

A Novel Preclinical Murine Model of Systemic Lupus Erythematosus–Like Cardiovascular Disease
di: Marice K. McCrorey, et al.
Pubblicazione: (2024-12-01)

Editorial: Heme proteins: key players in the regulation of immune responses
di: Volpi, C, et al.
Pubblicazione: (2023)

Uncovering molecular actors of IDO-mediated T cell dysfunction with genome-wide CRISPR/Cas9 knockout screens
di: Bombart, R, et al.
Pubblicazione: (2022)

A 31-plex panel for high-dimensional single-cell analysis of murine preclinical models of solid tumors by imaging mass cytometry
di: Yaël Glasson, et al.
Pubblicazione: (2023-01-01)

Correction: Circulating tumor cell-derived preclinical models: current status and future perspectives
di: Zuzana Kahounová, et al.
Pubblicazione: (2024-07-01)

Systemic tryptophan homeostasis
di: Klaessens, S, et al.
Pubblicazione: (2022)

MRI and MRS alterations in the preclinical phase of murine prion disease: association with neuropathological and behavioural changes.
di: Broom, K, et al.
Pubblicazione: (2007)

Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism
di: Zhu, J, et al.
Pubblicazione: (2018)

Secondary Ischemia Assessment in Murine and Rat Preclinical Subarachnoid Hemorrhage Models: A Systematic Review
di: Elias Fürstenau, et al.
Pubblicazione: (2024-03-01)

Preclinical Activity of Two Paclitaxel Nanoparticle Formulations After Intraperitoneal Administration in Ovarian Cancer Murine Xenografts
di: Demuytere J, et al.
Pubblicazione: (2024-01-01)

MRI and MRS alterations in the preclinical phase of murine prion disease: Association with neuropathological and behavioural changes
di: Kerry A. Broom, et al.
Pubblicazione: (2007-06-01)

Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors
di: Andrea Cavazzoni, et al.
Pubblicazione: (2023-03-01)

Characterization of retinal function and structure in the MPTP murine model of Parkinson’s disease
di: Katie K. N. Tran, et al.
Pubblicazione: (2022-05-01)

Preclinical Models of Pediatric Brain Tumors—Forging Ahead
di: Tara H.W. Dobson, et al.
Pubblicazione: (2018-10-01)

Preclinical Ward Teaching Student's Perspective
di: Tehreem Fatima, et al.
Pubblicazione: (2014-06-01)

Trophic and immunomodulatory effects of adipose tissue derived stem cells in a preclinical murine model of endometriosis
di: Toyofumi Hirakawa, et al.
Pubblicazione: (2022-05-01)

In Vivo Murine-Matured Human CD3+ Cells as a Preclinical Model for T Cell-Based Immunotherapies
di: Kevin G. Haworth, et al.
Pubblicazione: (2017-09-01)

Preclinical Evaluation of Anti-HIV-1 Polybiguanide Vaginal Microbicides in a Murine Model of Toxicity and Inflammation
di: Krebs Fred C, et al.
Pubblicazione: (2005-12-01)

Blood–Brain Barrier Dysfunction in Mild Traumatic Brain Injury: Evidence From Preclinical Murine Models
di: Yingxi Wu, et al.
Pubblicazione: (2020-08-01)

Photoacoustic-based oxygen saturation assessment of murine femoral bone marrow in a preclinical model of leukemia
di: Cayla Wood, et al.
Pubblicazione: (2019-06-01)